Biotech
During 2023, Switzerland’s biotech sector again demonstrated considerable agility particularly in commercialization and financing activities to continue to play a key role in driving global healthcare innovation.
Read more
The Paris Agreement requires Brazil to plant approximately 10 million ha of seedlings for reforestation by 2030
Read more
El Niño has generated extreme heat waves in many regions of Brazil, which are expected to occur until mid-April 2024. In other locations, excess rainfall has also been damaging agricultural production.
Read more
During 2022, Switzerland’s biotech industry again showed its resilience by adjusting to geopolitical disruptions while continuing to play a key role in driving global healthcare innovation. The Swiss biotech companies overall recorded revenues of CHF 6.8 billion.
Read more
The Covid-19 pandemic has shown the vulnerability of the world to airborne viruses, the outbreaks of which are very difficult to contain. This pandemic is certainly not the last, as a study published in the journal Nature shows that the loss of biodiversity
Read more
Many large investors allocate huge funds for biotechnological developments. Even before the pandemic, Bill Gates, Jeff Bezos and others had been investing in bio-startups for several years. After the appearance of COVID-19, interest in the pharmaceutical industry increased several times.
Read more
Biotechnologies are one of the key segments of the modern high-tech economy, a capacious and fast-growing global market. According to experts (Researchandmarkets), the projected volume of this market for 2022 is estimated at 1.4 trillion US dollars
Read more